1. Home
  2. MRUS vs RNST Comparison

MRUS vs RNST Comparison

Compare MRUS & RNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • RNST
  • Stock Information
  • Founded
  • MRUS 2003
  • RNST 1904
  • Country
  • MRUS Netherlands
  • RNST United States
  • Employees
  • MRUS N/A
  • RNST N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • RNST Major Banks
  • Sector
  • MRUS Health Care
  • RNST Finance
  • Exchange
  • MRUS Nasdaq
  • RNST Nasdaq
  • Market Cap
  • MRUS 2.7B
  • RNST 2.2B
  • IPO Year
  • MRUS 2016
  • RNST N/A
  • Fundamental
  • Price
  • MRUS $43.06
  • RNST $28.18
  • Analyst Decision
  • MRUS Strong Buy
  • RNST Buy
  • Analyst Count
  • MRUS 13
  • RNST 6
  • Target Price
  • MRUS $86.85
  • RNST $42.80
  • AVG Volume (30 Days)
  • MRUS 872.0K
  • RNST 1.7M
  • Earning Date
  • MRUS 05-07-2025
  • RNST 04-22-2025
  • Dividend Yield
  • MRUS N/A
  • RNST 3.12%
  • EPS Growth
  • MRUS N/A
  • RNST 27.73
  • EPS
  • MRUS N/A
  • RNST 3.27
  • Revenue
  • MRUS $36,133,000.00
  • RNST $706,583,000.00
  • Revenue This Year
  • MRUS $26.81
  • RNST $37.68
  • Revenue Next Year
  • MRUS $23.85
  • RNST $18.01
  • P/E Ratio
  • MRUS N/A
  • RNST $8.62
  • Revenue Growth
  • MRUS N/A
  • RNST 14.55
  • 52 Week Low
  • MRUS $33.19
  • RNST $26.97
  • 52 Week High
  • MRUS $61.61
  • RNST $39.63
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 51.15
  • RNST 31.28
  • Support Level
  • MRUS $33.19
  • RNST $27.68
  • Resistance Level
  • MRUS $43.46
  • RNST $28.50
  • Average True Range (ATR)
  • MRUS 3.53
  • RNST 1.50
  • MACD
  • MRUS 0.34
  • RNST -0.23
  • Stochastic Oscillator
  • MRUS 80.53
  • RNST 16.46

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: community banks, insurance, and wealth management. With its community banks segment, the company provides a range of financial services to individuals and small businesses. Its insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The wealth management segment provides a range of services including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment. Renasant Corporation operates in the southern United States.

Share on Social Networks: